A detailed history of Delta Financial Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Delta Financial Group, Inc. holds 2,219 shares of NVS stock, worth $252,855. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,219
Previous 2,219 -0.0%
Holding current value
$252,855
Previous $236,000 8.05%
% of portfolio
0.09%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$92.57 - $107.37 $462 - $536
5 Added 0.23%
2,219 $236,000
Q1 2024

Apr 30, 2024

BUY
$95.27 - $108.47 $4,191 - $4,772
44 Added 2.03%
2,214 $214,000
Q4 2023

Jan 18, 2024

SELL
$92.27 - $101.54 $276 - $304
-3 Reduced 0.14%
2,170 $219,000
Q3 2023

Oct 31, 2023

BUY
$94.73 - $105.13 $13,735 - $15,243
145 Added 7.15%
2,173 $221,000
Q2 2023

Jul 10, 2023

BUY
$92.52 - $104.91 $187,630 - $212,757
2,028 New
2,028 $205,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Delta Financial Group, Inc. Portfolio

Follow Delta Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Group, Inc. with notifications on news.